NEWSLETTER:
April 2012 > [30 KB]
Februar 2012 > [32 KB]
Dezember 2011 > [67 KB]
Oktober 2011 > [28 KB]
August 2011 > [26 KB]
Juni 2011 > [28 KB]
April 2011 > [70 KB]
Februar 2011 > [67 KB]
Januar 2011 > [22 KB]
November 2010 > [106 KB]

S3-Leitlinien Hormontherapie:
Kurzversion > [83 KB]
Langversion > [1.016 KB]

Brustkrebs & Hormontherapie 2010:
- Was darf nach der E3N-Studie als gesichert gelten? > [249 KB]

Postmenopausal Hormon Therapy
- An Endocrine Society Scientific Statement 2010 > [3.521 KB]

Stopping HRT-were women ill advised? > [25 KB]

Postmenopausale Hormontherapie und kardiovaskuläre Erkrankungen unter Berücksichtigung des Alters und Zeitpunkt der Menopause > [25 KB]

Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists > [353 KB]

Shifting Breast Cancer Trends in the United States > [14 KB]

Kommentar zur Studie von Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trialD. von Mühlen et al, Osteoporos Int (2008) 19:699-707 [15 KB]

Dehydroepiandrosterone Sulfate Levels Are Associated with More Favorable Cognitive Function in Women > [15 KB]

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis > [236 KB]